Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1982 1
1985 1
1986 1
1988 1
1989 1
1992 1
1995 1
1997 1
1998 2
2000 2
2001 2
2002 3
2003 2
2004 1
2005 3
2006 3
2007 4
2009 5
2010 1
2011 6
2012 9
2013 21
2014 29
2015 43
2016 57
2017 74
2018 65
2019 73
2020 89
2021 92
2022 84
2023 88
2024 34

Text availability

Article attribute

Article type

Publication date

Search Results

656 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Melasma treatment: a systematic review.
Neagu N, Conforti C, Agozzino M, Marangi GF, Morariu SH, Pellacani G, Persichetti P, Piccolo D, Segreto F, Zalaudek I, Dianzani C. Neagu N, et al. J Dermatolog Treat. 2022 Jun;33(4):1816-1837. doi: 10.1080/09546634.2021.1914313. Epub 2022 Mar 23. J Dermatolog Treat. 2022. PMID: 33849384 Free article. Review.
No single treatment is universally efficacious. Systemic treatments with tranexamic acid and polypodium leucotmatous had promising results, although the former was related to systemic side effects. Microneedling and peeling were also efficacious, although the …
No single treatment is universally efficacious. Systemic treatments with tranexamic acid and polypodium leucotmatous had promi …
Topical Treatments for Melasma and Their Mechanism of Action.
González-Molina V, Martí-Pineda A, González N. González-Molina V, et al. J Clin Aesthet Dermatol. 2022 May;15(5):19-28. J Clin Aesthet Dermatol. 2022. PMID: 35642229 Free PMC article. Review.
METHODS: A systematic review from PubMed database was performed, using PRISMA guidelines. The search was limited to English and Spanish studies that were double or single blinded, prospective, controlled or randomized clinical trials, rev …
METHODS: A systematic review from PubMed database was performed, using PRISMA guidelines. The search was limited to English and Spanish s …
Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Bala HR, et al. Dermatol Surg. 2018 Jun;44(6):814-825. doi: 10.1097/DSS.0000000000001518. Dermatol Surg. 2018. PMID: 29677015 Review.
BACKGROUND: Melasma is a common acquired disorder of hyperpigmentation that commonly affects those with skin of color. Tranexamic acid (TXA) is a novel treatment for melasma that has a multimodal mechanism of action. ...It is also a safe therapeutic option, which is …
BACKGROUND: Melasma is a common acquired disorder of hyperpigmentation that commonly affects those with skin of color. Tranexamic …
Melasma Treatment: An Evidence-Based Review.
McKesey J, Tovar-Garza A, Pandya AG. McKesey J, et al. Am J Clin Dermatol. 2020 Apr;21(2):173-225. doi: 10.1007/s40257-019-00488-w. Am J Clin Dermatol. 2020. PMID: 31802394
METHODS: A systematic literature search of the PubMed electronic database was performed using the keywords 'melasma' and/or 'chloasma' in the title, through October 2018. The search was then limited to 'randomized controlled trial' and 'controlled c …
METHODS: A systematic literature search of the PubMed electronic database was performed using the keywords 'melasma' and/or 'chloasma' in th …
Topical application of tranexamic acid for the reduction of bleeding.
Ker K, Beecher D, Roberts I. Ker K, et al. Cochrane Database Syst Rev. 2013 Jul 23;(7):CD010562. doi: 10.1002/14651858.CD010562.pub2. Cochrane Database Syst Rev. 2013. PMID: 23881695 Free article. Review.
SELECTION CRITERIA: Randomised controlled trials comparing topical tranexamic acid with no topical tranexamic acid or placebo in bleeding patients. ...There was substantial statistical heterogeneity between …
SELECTION CRITERIA: Randomised controlled trials comparing topical tranexamic acid with no topi …
Tranexamic acid in melasma: A focused review on drug administration routes.
Konisky H, Balazic E, Jaller JA, Khanna U, Kobets K. Konisky H, et al. J Cosmet Dermatol. 2023 Apr;22(4):1197-1206. doi: 10.1111/jocd.15589. Epub 2023 Jan 6. J Cosmet Dermatol. 2023. PMID: 36606378 Review.
Tranexamic acid (TXA) is a plasmin inhibitor used off-label in the treatment of melasma. ...PATIENTS/METHODS: A comprehensive PubMed and Embase search was conducted in May 2022 using the phrases tranexamic acid and melasma. ...
Tranexamic acid (TXA) is a plasmin inhibitor used off-label in the treatment of melasma. ...PATIENTS/METHODS: A compreh …
Safety and efficacy of mesotherapy in the treatment of melasma: A review article.
Khalili M, Amiri R, Iranmanesh B, Zartab H, Aflatoonian M. Khalili M, et al. J Cosmet Dermatol. 2022 Jan;21(1):118-129. doi: 10.1111/jocd.14644. Epub 2021 Nov 30. J Cosmet Dermatol. 2022. PMID: 34846788 Review.
Exclusion criteria were articles in languages other than English or non-human studies. RESULTS: Thirty-three articles evaluated efficacy of mesotherapy in melasma, including 28 articles about tranexamic acid, 4 articles about vitamin C, 2 articles about gluta …
Exclusion criteria were articles in languages other than English or non-human studies. RESULTS: Thirty-three articles evaluated effic …
Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.
Desai S, Chan L, Handog E, Djojoseputro L, Lim J, Ling R, Nguyen H, Tam E, Tang J, Thng S, Tran H. Desai S, et al. J Drugs Dermatol. 2023 Apr 1;22(4):386-392. doi: 10.36849/JDD.7104. J Drugs Dermatol. 2023. PMID: 37026889 Review.
Nonetheless, it is limited by its side effect profile. Certain patient profiles who have had prior therapy and/or are refractory to treatment may be offered an alternative, that is topical tranexamic acid (TXA) alone or in combination with other …
Nonetheless, it is limited by its side effect profile. Certain patient profiles who have had prior therapy and/or are refracto …
Efficacy of topical tranexamic acid in epistaxis: A systematic review and meta-analysis.
Janapala RN, Tran QK, Patel J, Mehta E, Pourmand A. Janapala RN, et al. Am J Emerg Med. 2022 Jan;51:169-175. doi: 10.1016/j.ajem.2021.10.043. Epub 2021 Nov 1. Am J Emerg Med. 2022. PMID: 34763235
Over the years several studies have investigated the potential use of topical Tranexamic Acid (TXA) in the management of epistaxis. ...RESULTS: A total of eight studies were included in the analysis, including seven randomized trials …
Over the years several studies have investigated the potential use of topical Tranexamic Acid (TXA) in the manag …
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 2 factorial, randomised, double-blind, controlled trial.
Lasocki S, Capdevila X, Vielle B, Bijok B, Lahlou-Casulli M, Collange V, Grillot N, Danguy des Deserts M, Duchalais A, Delannoy B, Drugeon B, Bouzat P, David JS, Rony L, Loupec T, Léger M, Rineau E; HiFIT Investigators; SFAR research network. Lasocki S, et al. Lancet Haematol. 2023 Sep;10(9):e747-e755. doi: 10.1016/S2352-3026(23)00163-1. Epub 2023 Jul 28. Lancet Haematol. 2023. PMID: 37524101 Clinical Trial.
We evaluated the efficacy of intravenous iron and tranexamic acid in reducing blood transfusions after hip fracture surgery. ...FINDINGS: Of 413 patients (51-104 years old, median [IQR] 86 [78-91], 312 [76%] women, 101 [24%] men), 104 received iron plu …
We evaluated the efficacy of intravenous iron and tranexamic acid in reducing blood transfusions after hip fracture sur …
656 results